Certificate of Analysis
HEMP QUALITY ASSURANCE TEST

Sample Name:

Roller

Infused, Topical

Date Issued:

11/24/2023

Total THC 2.264 mg/mL
Total CBD 62.188 mg/mL
Sum Cannabinoids 67.695 mg/mL
Total Cannabinoids 67.510 mg/mL

Sample Information

Sample Details

Sample ID:231120T012

Batch Number:Roll.11.07.23

Cultivator / Manufacturer

Show Details

Distributor / Tested For

Show Details

Share

Easily share a link to this results page with your friends, followers, or business partners.

Cannabinoid Analysis - Summary

Total THC: 2.264 mg/mL

Total CBD: 62.188 mg/mL

Sum of Cannabinoids: 67.695 mg/mL

Total Cannabinoids: 67.510 mg/mL

Density:0.9473 g/mL

Total THC/CBD is calculated using the following formulas to take into account the loss of a carboxyl group during the decarboxylation step:
Total THC = Δ9-THC + (THCa (0.877))
Total CBD = CBD + (CBDa (0.877))

Sum of Cannabinoids = Δ9-THC + THCa + CBD + CBDa + CBG + CBGa + THCV + THCVa + CBC + CBCa + CBDV + CBDVa + Δ8-THC + CBL + CBN

Total Cannabinoids = (Δ9-THC+0.877*THCa) + (CBD+0.877*CBDa) + (CBG+0.877*CBGa) + (THCV+0.877*THCVa) + (CBC+0.877*CBCa) + (CBDV+0.877*CBDVa) + Δ8-THC + CBL + CBN

Sum of Cannabinoids: The concentration of each individual cannabinoid added together as they are, without accounting for decarboxylation. This measurement is of particular importance for certain cannabis products that are not intended to be heated prior to application or consumption.

Total Cannabinoids: The concentration of each acidic cannabinoid, multiplied by 0.877 to account for the loss of molecular mass that happens as it is converted to a neutral cannabinoid when heated. Then this calculated concentration is added to the concentrations of the corresponding neutral cannabinoid already present. This corrected data is of particular importance to both producers and consumers of products intended to be heated prior to application or consumption.

View Complete Test Results:

Tested by high-performance liquid chromatography with diode-array detection (HPLC-DAD).

Method: QSP 1157 - Analysis of Cannabinoids by HPLC-DAD

Summary

Total THC: 2.264 mg/mL

9-THC+0.877*THCa)

Total CBD: 62.188 mg/mL

(CBD+0.877*CBDa)

Total Cannabinoids: 67.510 mg/mL

Total CBG: ND

Total CBG (CBG+0.877*CBGa)

Total THCV: ND

Total THCV (THCV+0.877*THCVa)

Total CBC: 1.913 mg/mL

Total CBC (CBC+0.877*CBCa)

Total CBDV: 0.259 mg/mL

Total CBDV (CBDV+0.877*CBDVa)

Learn more

The cannabis plant contains dozens of active compounds called cannabinoids. These compounds are the primary contributors to the psychoactive effects of cannabis.

Cannabinoid testing determines the potency of a sample to aid in dosage considerations.

Cannabinoid Test Results

11/24/2023

Result Views

Swipe left on table to see additional columns

Compound LOD/LOQ
(mg/mL)
Measurement
Uncertainty
(mg/mL)
Result
(mg/mL)
Result
(%)
Cannabidiol (CBD) 0.004 / 0.011 ±2.2729 60.935 6.4325
Δ9 Tetrahydrocannabinol (Δ9THC) 0.002 / 0.014 ±0.1243 2.264 0.2390
Cannabichromene (CBC) 0.003 / 0.010 ±0.0596 1.851 0.1954
Cannabidiolic Acid (CBDa) 0.001 / 0.026 ±0.0406 1.429 0.1508
Cannabinol (CBN) 0.001 / 0.007 ±0.0228 0.796 0.0840
Cannabidivarin (CBDV) 0.002 / 0.012 ±0.0106 0.259 0.0273
Cannabicyclol (CBL) 0.003 / 0.010 ±0.0033 0.090 0.0095
Cannabichromenic Acid (CBCa) 0.001 / 0.015 ±0.0027 0.071 0.0075
Cannabigerol (CBG) 0.002 / 0.006 N/A ND ND
Cannabigerolic Acid (CBGa) 0.002 / 0.007 N/A ND ND
Tetrahydrocannabivarin (THCV) 0.002 / 0.012 N/A ND ND
Tetrahydrocannabinolic Acid (THCa) 0.001 / 0.005 N/A ND ND
Cannabidivarinic Acid (CBDVa) 0.001 / 0.018 N/A ND ND
Tetrahydrocannabivarinic Acid (THCVa) 0.002 / 0.019 N/A ND ND
∆8 Tetrahydrocannabinol (Δ8THC) 0.01 / 0.02 N/A ND ND
SUM OF CANNABINOIDS 67.695 mg/mL 7.1461%
Density Test Result

0.9473 g/mL Tested 11/24/2023 Method: QSP 7870 - Sample Preparation

Learn more

The cannabis plant contains dozens of active compounds called cannabinoids. These compounds are the primary contributors to the psychoactive effects of cannabis.

Cannabinoid testing determines the potency of a sample to aid in dosage considerations.

Your current browser is unsupported. Please install latest version of Firefox, Chrome or IE to view this site.